Detalhe da pesquisa
1.
HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species.
Nat Immunol
; 11(3): 265-72, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20139987
2.
BCL2 inhibition: back to the future!
Blood
; 143(18): 1787-1788, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696193
3.
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
Blood
; 133(26): 2765-2775, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862645
4.
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
Genes Chromosomes Cancer
; 59(4): 261-267, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31677197
5.
Specific interactions of BCL-2 family proteins mediate sensitivity to BH3-mimetics in diffuse large B-cell lymphoma.
Haematologica
; 105(8): 2150-2163, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601689
6.
CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL.
J Cell Mol Med
; 23(1): 340-348, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30353642
7.
Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis.
Br J Haematol
; 184(6): 957-968, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548597
8.
Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies.
Haematologica
; 104(5): 1016-1025, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467206
9.
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT.
Blood
; 128(25): 2899-2908, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802969
10.
Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
Blood
; 128(19): 2319-2326, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27528712
11.
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.
Blood
; 127(4): 411-9, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26542378
12.
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib.
Blood
; 127(23): 2847-55, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26941398
13.
Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment.
Br J Haematol
; 178(3): 364-379, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449207
14.
Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
Blood
; 126(8): 1005-8, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26065650
15.
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.
Haematologica
; 102(4): 765-772, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011903
16.
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study.
Haematologica
; 102(5): 903-909, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126962
17.
Enhanced activation of an amino-terminally truncated isoform of the voltage-gated proton channel HVCN1 enriched in malignant B cells.
Proc Natl Acad Sci U S A
; 111(50): 18078-83, 2014 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425665
18.
Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.
Br J Haematol
; 175(4): 641-651, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469405
19.
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
Br J Haematol
; 173(2): 265-73, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26917488
20.
Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study.
Haematologica
; 106(10): 2774-2778, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233448